Streetbeat News

CLOV

Clover Health Investments, Corp.

https://www.cloverhealth.com

Industry

Medical - Healthcare Plans

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Open

3.00

Mkt cap

1.5B

Volume

High

3.08

P/E Ratio

-16.00

52-wk high

4.71

Low

2.99

Div yield

N/A

52-wk low

0.61

The Biden-Harris Administration has proposed a Medicare $2 Drug List Model aimed at reducing prescription costs. The Centers for Medicare & Medicaid Services (CMS) is seeking feedback on a sample drug list and plans to start voluntary participation for Part D sponsors as early as January 2027. The model will include drugs for common conditions and will be updated periodically based on new generics, clinical indications, and pricing trends.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 12:57 pm

Clover Health Investments shares are trading lower following UBS's initiation of coverage with a Neutral rating and a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 4:48 pm

UBS has initiated coverage on Clover Health Investments with a Neutral rating and set a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 3:32 pm

Portfolio Pulse from Benzinga Newsdesk

October 04, 2024 | 1:22 pm

Clover Health Investments (NYSE:CLOV) has seen a 28.4% increase in short interest, with 25.80 million shares sold short, representing 6.42% of its float. This is higher than its peers' average of 3.83%. The rise in short interest suggests bearish sentiment, but it could also present a bullish opportunity if the stock price rises.

Portfolio Pulse from Benzinga Insights

October 03, 2024 | 2:00 pm

Nvidia, Palantir, Clover Health, Joby Aviation, and Tesla are in focus due to recent stock movements and news. Nvidia's partnership with Accenture boosts its stock, while Palantir's stock rises after Peter Thiel's share sale. Clover Health and Joby Aviation see significant gains due to social media traction and Toyota's investment, respectively. Tesla's stock drops despite exceeding delivery expectations.

Portfolio Pulse from Benzinga Neuro

October 03, 2024 | 2:42 am

Clover Health's stock surged over 29% due to increased trading volume and social media traction. The rise follows a multi-year agreement with The Iowa Clinic and the appointment of a new COO. Additionally, short interest in the stock has decreased.

Portfolio Pulse from Vaishali Prayag

October 02, 2024 | 8:11 pm

Several healthcare stocks experienced significant intraday movements on Wednesday. Notable gainers included Inspire Veterinary, ModivCare, and I-MAB, while Eagle Pharmaceuticals and Windtree Therapeutics were among the biggest losers.

Portfolio Pulse from Benzinga Insights

October 02, 2024 | 4:31 pm

RPM International reported better-than-expected earnings, leading to a 7.2% rise in its stock. Other stocks like Joby Aviation and Ciena Corporation also saw gains due to positive developments.

Portfolio Pulse from Avi Kapoor

October 02, 2024 | 3:41 pm

Clover Health Investments, Corp. (NASDAQ:CLOV) has appointed Joseph Brand as Chief Operating Officer for its Medicare Advantage operations. Brand, with nearly 20 years of healthcare leadership experience, will focus on improving healthcare delivery in New Jersey through operational efficiencies and technological innovation.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2024 | 8:02 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.